Rifampicin is an inducer of the hepatic mixed function oxygenase enzymes involved in drug metabolism.' 2 Needle biopsy specimens of the liver from patients receiving rifampicin show an increase in cytochrome P4503 and proliferation of smooth endoplasmic reticulum in the hepatocytes.4 Rifampicin induces its own metabolism' during continuous treatment as demonstrated by a shortened half life. In addition, rifampicin can accelerate the elimination of the contraceptive pill,6 leading to menstrual disturbance and unwanted pregnancy. Tolbutamide, hexobarbitone,7 and oral anticoagulants8 are other drugs whose metabolism is similarly affected. Deterioration in renal9 and allograft function'0 associated with concomitant rifampicin treatment may be cited as indirect evidence of the effect of this drug on steroid metabolism.
Horm Metab Res 1980;12:229-30. 13 Striffler JS, Curry DL. Effect of fasting on insulin removal by liver of perfused liver-pancreas. Am Rifampicin is an inducer of hepatic drug metabolising enzymes. This results in interactions with several drugs including oral anticoagulants, hypoglycaemics, and contraceptives. Concurrent treatment with prednisolone and rifampicin is given when tuberculosis coexists with a disease that is sensitive to steroids, when the diagnosis is uncertain, or occasionally in the treatment of severe tuberculosis. Two patients with respiratory disease were treated with both drugs: their condition improved considerably after rifampicin was withdrawn. Seven patients were then studied to assess the effect of rifampicin on the pharmacokinetics of prednisolone. Overall, rifampicin increased the plasma clearance of prednisolone by 45% and reduced the amount of drug available to the tissues (area under the plasma concentration time curve) by 66%. The effectiveness of prednisolone may be considerably reduced when rifampicin and predm'solone are used in combination.
Introduction
Rifampicin is an inducer of the hepatic mixed function oxygenase enzymes involved in drug metabolism.' 2 Needle biopsy specimens of the liver from patients receiving rifampicin show an increase in cytochrome P4503 and proliferation of smooth endoplasmic reticulum in the hepatocytes.4 Rifampicin induces its own metabolism' during continuous treatment as demonstrated by a shortened half life. In addition, rifampicin can accelerate the elimination of the contraceptive pill,6 leading to menstrual disturbance and unwanted pregnancy. Tolbutamide, hexobarbitone,7 and oral anticoagulants8 are other drugs whose metabolism is similarly affected. Deterioration in renal9 and allograft function'0 associated with concomitant rifampicin treatment may be cited as indirect evidence of the effect of this drug on steroid metabolism.
We report on two patients with respiratory disease in whom rifampicin affected metabolism of steroids; and we describe a study of the effects of rifampicin on the pharmacokinetics of prednisolone in seven patients.
Case reports CASE 1
A 16 year old boy presented with a year's history of symmetrical polyarthropathy, early morning stiffness, and lassitude. Finger clubbing and a rheumatoid nodule at the elbow were noted, and investigation showed a high erythrocyte sedimentation rate and the presence of rheumatoid factor. Rheumatoid arthritis was diagnosed.
A chest x-ray film showed bilateral hilar lymphadenopathy and midzone reticular shadowing. As the most likely diagnosis was thought to be tuberculosis treatment with rifampicin and isoniazid was started. He developed pyrexia, which was ascribed to a possible hypersensitivity reaction to one of these drugs. In The pharmacokinetics of prednisolone were studied twice in five patients, when they were taking prednisolone alone and on a separate occasion when they were also taking rifampicin. Two further patients were studied only while taking rifampicin and prednisolone as it proved impossible to perform the second study. The age range was 16-65 years and weight range 45-75 kg. All subjects had normal renal and hepatic function before the study, but transient slight rises in hepatic enzyme activities were seen at the onset of antituberculous treatment. The study of prednisolone alone was performed either before antituberculous treatment was started or at least a month after it was stopped to allow any residual effect of rifampicin to be eliminated. Two subjects (cases 2 and 3) were studied before and three (cases 1, 4, and 5) after antituberculous treatment (table). All patients had taken prednisolone for at least five days before the day of the study of prednisolone alone. All patients had taken rifampicin and prednisolone for at least a month before the study of the two drugs.
The patients were given 20 mg prednisolone at 0800 after an overnight fast. No food or beverages were taken over the ensuing three hours, and meals thereafter were identical on both study days. Blood samples were taken via an indwelling cannula at 0, 15, and 40 minutes and at one, two, three, four, six, and eight hours; plasma was stored at -200C.
Plasma prednisolone concentration was measured by quantitative thin layer chromatography with fluorescence detection using a method described previously" and later further modified.12 The 
RESULTS
The table shows the values of the pharmacokinetic variables of prednisolone in all the patients studied during concurrent treatment with rifampicin and when no rifampicin was given. There was a significant increase in the systemic clearance and reduction in the area under the curve for prednisolone when rifampicin was given: the g24 BRITISH MEDICAL JOURNAL VOLUME 286 mean area under the curve was reduced to less than half (66% reduction) (p=0001) and the mean clearance increased by 45% (p=0 001). This effect was seen irrespective of whether the study of pred1isolone alone was before or after the course of antituberculous treatment and was a consistent finding in all subjects in whom both treatments were given. The plasma half life and maximum plasma concentration were unaltered. There was a wide interindividual variation in the plasma half life of prednisolone, which agrees with the findings of others. 16 
Discussion
There is a wide range of conditions that is responsive to steroids and during the course of which tuberculosis may develop and treatment with rifampicin be added. Such conditions, for which steroids are often essential, are as varied as asthma, systemic lupus and other connective tissue disorders, fibrosing alveolitis, and glomerulonephritis; the problem also arises in patients receiving post-transplantation regimens and cancer chemotherapy. Corticosteroids are occasionally used temporarily as part of the treatment of tuberculosis or in reducing oedema in those with a cerebral or spinal tuberculous abscess impinging dangerously on neurological structures. Alternatively the combination of rifampicin and prednisolone may be used when the diagnosis is not clear and tuberculosis cannot be excluded. In particular, it can be difficult to distinguish histologically and clinically between tuberculosis and sarcoidosis. If rifampicin and prednisolone are used in combination in any of these circumstances the steroid is exerting considerably less effect than might be expected. The case histories above illustrate this point and underline how easily failure to respond to treatment may be ascribed to the severity of the illness rather than to drug interaction. It is important to note that once rifampicin was stopped in case 8 the patient's condition improved despite continued treatment with ethambutol and isoniazid, implying that rifampicin alone was exerting the deleterious effect.
Possible clinical effects of rifampicin in patients dependent on prednisolone have been reported.9 10 Edwards et a 17 described a patient with Addison's disease who required an increased corticosteroid dose while receiving rifampicin. However, apart from one case report9 of reduced half life of prednisolone in a young boy determined by using a radiolabelled tracer no quantitative studies of the effect of rifampicin on the metabolism of prednisolone have been carried out.
Our pharmacokinetic study shows a pronounced effect of rifampicin on the metabolism of prednisolone. Although rifampicin is a hepatic enzyme inducer, the precise mechanism of the interaction cannot be distinguished. The core observation is that the area under the prednisolone curve, which is a model independent variable based solely on observations without any interpretation as to mechanism, is reduced with rifampicin. The area under the curve roughly represents the amount of drug available to the tissues, and a 66% reduction in this might have serious consequences if not compensated for by adjustment of the dosage. Not only may patients in whom disease control depends on prednisolone suffer exacerbation of disease, but a condition that responds to steroids may be overlooked if rifampicin is administered concurrently. The consequences are particularly important as in many cases there are no viable alternatives to corticosteroid treatment and the findings above are probably qualitatively true for all steroids. Rifampicin remains an extremely useful antituberculous agent, and an alternative to changing to other chemotherapy would be to at least double the dose of prednisolone if rifampicin is to be administered simultaneously.
ONE HUNDRED YEARS AGO
Dr. Horace Dobell, in a letter published in the Times of September 18th, draws attention to the bad effects of the "braces system of suspension" for women's dress. He urges that the hips, and not the shoulders, are the best part of the human frame for the support of weight. He adds that "braces restrict the elevation and antero-posterior expansion of the chest; and important as these movements are to men, they are far more so to women." There is doubtless much truth in Dr. Dobell's remarks, but we trust that his assertion that the system of suspension of the clothes from the shoulders is the outcome of the arguments used by "dress reformers" against tight lacing, will not be seized by the ladies as a statement in favour of continuing the use of stays. The evils referred to by Dr. Dobell, doubtless are often produced by the use of braces, and especially when a heavy weight is suspended. This weight is often unnecessarily great in consequence of the looseness of ladies' clothing. If, instead of hanging a quantity of loose clothes round the legs, the garments covering these extremities were chiefly close-fitting, the weight of the clothing might be very much lessened, because when close to the body they preserve the warmth much better than when surrounding the legs loosely. The principle of dual garments might be carried on without altering the external appearance of female dress; for, with the use of warm, close-fitting drawers or trousers, the outer skirts might be made in the usual manner, but of much less thickness and weight. Many ladies now wear neither stays nor suspenders, and yet experience no difficulty in supporting their skirts, chiefly upon the hips. (British Medical3Journal, 1883;ii :640.)
